Steffen Pietzke

CIK 1647008 · Chief Financial Officer · last filed 2023-07-07

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.14M

Companies

4

Total Filings

45

Lifetime Open-Market Net

$626.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ENVX Chief Financial Officer 621,385 $6.66 $4.14M $295.0K 32 2023-07-07
ALXO VP Fin & Chief Acct Officer 3,000 $1.58 $4.7K $57.0K 2 2020-07-21
Tricida, Inc. (TCDA) Delisted VP Fin & Chief Acct Officer 10,527 $0.11 $1.1K $200.0K 4 2020-02-26
PDL BIOPHARMA, INC. (PDLI) Delisted VP, Finance and CAO 160,177 $74.9K 7 2017-12-19

Recent Filings · Page 5 of 5

45 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-12-15 PDL BIOPHARMA, INC. (PDLI) Delisted Disp (D) −663 $0 EDGAR
2016-01-28 PDL BIOPHARMA, INC. (PDLI) Delisted Grant (A) +31,135 $100.3K EDGAR
2015-12-07 PDL BIOPHARMA, INC. (PDLI) Delisted Buy (P) +20,590 $74.9K EDGAR
2015-10-05 PDL BIOPHARMA, INC. (PDLI) Delisted Grant (A) +1,841 $9.1K EDGAR
2015-07-08 PDL BIOPHARMA, INC. (PDLI) Delisted Grant (A) +14,748 $91.1K EDGAR
Showing 4145 of 45
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.